The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...
S hares of Hims & Hers (NYSE: HIMS) fell as much as 15% on Thursday after news that Eli Lilly's (NYSE: LLY) GLP-1 drug was taken off the shortage list by the FDA. This could impac ...
The company has been doing incredibly well, and revenue as well as profits have skyrocketed in recent quarters. Shares of ...
Zacks.com on MSN18h
Company News for Oct 4, 2024
Levi Strauss & Co.’s (LEVI) shares plunged 7.7% after reporting third-quarter fiscal 2024 net revenues of $1,517 million, missing the Zacks Consensus Estimate of $1,552 million. Shares of ...
The robust hiring in September showed that the labor market remained strong. The unemployment rate dropped to 4.1 percent. Pandemic Start-Ups Are Thriving, and Helping to Fuel the Economy A record ...
Kent Precision Foods Group, Inc. of Muscatine, IA, is recalling Sqwincher Electrolyte Beverage Mix powder because of potential foreign material in the product, specifically metal. According to the ...